Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

December 31, 2020

Primary Completion Date

September 4, 2024

Study Completion Date

September 4, 2024

Conditions
Growth Hormone Deficiency
Interventions
DRUG

LUM-201

Administered orally once daily

DRUG

rhGH Norditropin® pen (34 µg/kg)

Administered subcutaneously (s.c., under the skin) once daily.

Trial Locations (43)

2605

Canberra Hospital, Garran

3052

Royal Children's Hospital, Melbourne

3168

Department of Pediatrics and Endocrinology- Monash Health, Clayton

6021

Wellington Regional Hospital CCDHB, Newtown

10016

NYU Grossman School of Medicine, New York

14203

UBMD Pediatrics, Buffalo

15224

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

17033

Penn State College of Medicine, Hershey

19104

The Children's Hospital of Philadelphia, Philadelphia

20010

Children's National Hospital, Washington D.C.

22908

University of Virginia Health System, Charlottesville

29425

Medical University of South Carolina, Charleston

30093

The Mount Sinai Hospital, Mount Sinai

30318

Atlanta Diabetes Associates, Atlanta

40202

Novak Center For Childrens Health, Louisville

43205

Nationwide Children's Hospital, Columbus

46202

Indiana University School of Medicine, Indianapolis

52242

University of Iowa, Iowa City

55102

Children's Minnesota, Saint Paul

55454

M Health, Fairview Pediatric Specialty Clinics- Discovery Clinic, Minneapolis

64111

The Children's Mercy Hospital, Kansas City

73104

University of Oklahoma Health Sciences Center, Pediatric Diabetes and Endocrinology, Oklahoma City

76104

Cook Children's Medical Center, Fort Worth

78229

Diabetes & Glandular Disease Clinic, P.A., San Antonio

79106

Texas Tech University Health Sciences Center, Amarillo

80111

Pediatric Endocrine Associates, Greenwood Village

92123

Rady Children's Hospital, San Diego

95821

Center of Excellence in Diabetes and Endocrinology, Sacramento

98105

Seattle Children's Hospital, Seattle

98405

MultiCare Institute for Research and Innovation, Tacoma

4920235

Schneider Children's Medical Center Institute for Endocrinology and Diabetes National Center, Petah Tikva

01655

UMass Memorial Medical Center, Worcester

Unknown

Queensland Children's Hospital, South Brisbane

Liggins Institute, University of Auckland, Auckland

Klinika Pediatrii, Endokrynologii, Diabetologii z Pododdziałem Kardiologii, Uniwersytecki Dziecięcy Szpital Kliniczny im.Ludwika Zamenhofa w Białymstoku, Bialystok

Klinika Endokrynologii i Chorob Metabolicznych, Instytut Centrum Zdrowia Matki Polki, Lodz

Klinika Pediatrii, Diabetologii i Endokrynologii Gdansk, Pomorskie

klinika Pediatrii, Endokrynologii i Diabetologii Dziecięcej, Rzeszów

Sonomed - Centrum Medyczne, Szczecin

"Klinika Endokrynologii i Diabetologii, Instytut Pomnik Centrum Zdrowia Dziecka", Warsaw

SP Dziecięcy Szpital Kliniczny w Warszawie, Warsaw

Klinika Endokrynologii i Diabetologii Wieku Rozwojowego UM, Wroclaw

04114

State Institution 'V. P. Komissarenko Institute of Endocrinology and Metabolism of the National academy of medical science of Ukraine, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Lumos Pharma

INDUSTRY